Ropharma is the fifth most extended pharmaceutical retail chain, with units in the Moldavia and Transylvania regions, operating in 15 counties.
Entrepreneur Mihai Miron, who controls Ropharma pharmacy chain, is one of the first investors in the medicine manufacturing sector, establishing Europharm in Brasov, a company he had sold to UK’s GSK at the end of the 1990s.
Ropharma Group operates in the medicine manufacturing and distribution sectors, as well as in the private medical services sector – The Sf. Constantin private hospital in Brasov.
Ropharma, the individual company, has 917 employees and carried out investments of RON10.5 million in 2019. For 2020, the investment budget remained unchanged, but the company targets revenue of RON522 million, which translates into a moderate growth compared with the previous years.
The pharmaceutical retail sector reached total sales of RON19 billion in 2018, the latest year for which public data are available, the combined amount of over 5,000 companies active on the market.
The top five players account for 27% of the total pharmacy market- some 2,200 units, per ZF calculations. The total number of pharmacies reaches 8,100 units, per statistic data.